Facebook tracking pixel
C79.51
ICD-10-CM
Metastatic Cancer to Bone

Find key information on metastatic cancer to bone, including diagnosis, staging, treatment options, and prognosis. This resource covers relevant healthcare terminology, clinical documentation best practices, and medical coding guidelines for ICD-10 and SNOMED CT related to bone metastases, secondary bone cancer, and skeletal metastases. Learn about diagnostic imaging, pain management, and palliative care considerations for patients with metastatic bone disease. This comprehensive guide is valuable for physicians, nurses, coders, and other healthcare professionals seeking accurate and up-to-date information.

Also known as

Bone Metastasis
Secondary Bone Cancer

Diagnosis Snapshot

Key Facts
  • Definition : Cancer spread to bone from a primary site, often breast, lung, prostate, or kidney.
  • Clinical Signs : Bone pain, fractures, fatigue, hypercalcemia. May be asymptomatic.
  • Common Settings : Oncology, palliative care, radiation oncology, orthopedic surgery.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC C79.51 Coding
C79.51

Secondary malignant neoplasm of bone

Specifies bone as the site of metastasis.

C79.50

Secondary malignant neoplasm, unspecified

Metastatic cancer with unspecified site, usable if bone not confirmed.

C00-C97

Malignant neoplasms

Broad range encompassing all malignant neoplasms, including primary cancers that may metastasize.

Z85

Personal history of malignant neoplasm

Relevant for patients with a history of primary cancer that could have metastasized to bone.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the primary cancer site known?

Documentation Best Practices

Documentation Checklist
  • Metastatic bone cancer diagnosis documentation
  • ICD-10-CM C79.51 secondary malignant neoplasm of bone
  • Confirm bone metastasis origin primary site
  • Document imaging findings: X-ray, CT, MRI, bone scan
  • Pathology report: biopsy or cytology confirmation
  • Symptom documentation: pain, fracture, hypercalcemia

Coding and Audit Risks

Common Risks
  • Unspecified Primary Site

    Coding metastatic cancer to bone without documented primary site leads to inaccurate coding and potential claim denials. Proper documentation is crucial.

  • Pathology Confirmation

    Lack of pathology report confirming bone metastasis can cause coding errors and compliance issues. CDI should query for supporting documentation.

  • Staging Documentation

    Insufficient documentation of the stage of the metastatic cancer impacts accurate code assignment and reimbursement. Clear staging is essential.

Mitigation Tips

Best Practices
  • Code accurately: C79.51, C79.52 for bone mets. Use correct laterality.
  • Document symptom onset, primary cancer site, and diagnostic tests (bone scan, PET).
  • Query physician for clarity if documentation lacks detail for accurate coding.
  • Educate physicians on complete bone mets documentation for compliant billing.
  • Regularly audit records for coding accuracy and compliance with ICD-10 guidelines.

Clinical Decision Support

Checklist
  • 1. Verify primary cancer diagnosis (ICD-10 C00-C97).
  • 2. Confirm bone metastasis evidence (imaging, biopsy).
  • 3. Document Sx onset, location, and characteristics.
  • 4. Evaluate for related hypercalcemia (ICD-10 E83.5).

Reimbursement and Quality Metrics

Impact Summary
  • Metastatic Cancer to Bone reimbursement hinges on accurate coding (ICD-10 C79.51, C79.52) and staging documentation for optimal payment.
  • Coding quality directly impacts Case Mix Index (CMI) and hospital reimbursement for bone metastasis cases.
  • Accurate coding and documentation are crucial for quality reporting initiatives and affect hospital value-based purchasing programs.
  • Physician queries for clarifying bone metastasis diagnosis and stage improve coding accuracy and minimize claim denials.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Code primary cancer site first
  • Use C79.51 for unspecified bone mets
  • Document bone mets location for specificity
  • Distinguish pathological fracture coding
  • Consider sequencing if bone is only site

Documentation Templates

Patient presents with complaints consistent with metastatic bone cancer.  Symptoms include bone pain, particularly in the spine, pelvis, and long bones, which may be described as constant, aching, or worse at night.  The patient may also report localized swelling, tenderness, and limited range of motion.  Pathologic fractures, hypercalcemia symptoms such as nausea, vomiting, constipation, and fatigue, and neurological symptoms secondary to spinal cord compression are possible.  History may reveal a primary cancer diagnosis such as breast cancer, lung cancer, prostate cancer, or multiple myeloma.  On physical exam, palpable bone lesions, decreased range of motion, and neurological deficits depending on the location of the metastasis may be observed.  Diagnostic workup includes imaging studies such as bone scan, X-ray, CT scan, MRI, and PET scan to assess the extent of bone involvement.  Laboratory tests including serum calcium, alkaline phosphatase, and complete blood count are performed to evaluate for hypercalcemia and other related abnormalities.  Biopsy of the affected bone is often necessary for histopathological confirmation of metastatic bone cancer and identification of the primary cancer origin.  Differential diagnoses include osteoporosis, osteomyelitis, and primary bone tumors.  Treatment planning for bone metastases involves a multidisciplinary approach, considering the patient's overall health status, primary cancer type, and extent of skeletal involvement.  Treatment options include radiation therapy for pain management and local tumor control, chemotherapy, bisphosphonates for hypercalcemia prevention and skeletal-related events, surgery for fracture stabilization or spinal cord compression relief, and targeted therapy or immunotherapy depending on the primary cancer type.  Referral to oncology, orthopedics, pain management, and palliative care may be indicated.  Patient education regarding pain management strategies, fall prevention, and potential complications is crucial.  Follow-up appointments are scheduled for monitoring treatment response, managing side effects, and addressing any new or worsening symptoms.